Infinity Pharmaceuticals (NASDAQ: INFI)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Infinity Pharmaceuticals (NASDAQ: INFI) through any online brokerage.
The latest price target for Infinity Pharmaceuticals (NASDAQ: INFI) was reported by Piper Sandler on Monday, May 23, 2022. The analyst firm set a price target for 3.00 expecting INFI to rise to within 12 months (a possible 408.47% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Infinity Pharmaceuticals (NASDAQ: INFI) is $0.59 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Infinity Pharmaceuticals.
Infinity Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, July 26, 2022.
There is no upcoming split for Infinity Pharmaceuticals.
Infinity Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.